Literature DB >> 687386

Childhood Hodgkin's disease in Uganda: a ten year experience.

C L Olweny, E Katongole-Mbidde, C Kiire, S K Lwanga, I Magrath, J L Ziegler.   

Abstract

Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available. Thirty-eight percent had early stage disease (stages I-IIIA). Prolonged first remissions were achieved in 74% of 42 complete responders. Of 11 patients who relapsed, 5 had prolonged second remissions induced by MOPP. Three patients were lost to follow-up and 15 of the remaining 45 died: 12 of these from progressive Hodgkin's disease, 2 from unrelated causes and 1 from Burkitt's lymphoma after 4 months remission from Hodgkin's disease. Acturial survival for all patients is 67% (75% for stages I-IIIA and 60% for stages IIIB-IV). Treatment complications included Herpes zoster and gynaecomastia. The latter is probably related to gonadal dysfunction. All stages of childhood Hodgkin's disease can be successfully managed with MOPP chemotherapy alone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687386     DOI: 10.1002/1097-0142(197808)42:2<787::aid-cncr2820420251>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.

Authors:  Monika L Metzger; Howard J Weinstein; Melissa M Hudson; Amy L Billett; Eric C Larsen; Alison Friedmann; Scott C Howard; Sarah S Donaldson; Matthew J Krasin; Larry E Kun; Karen J Marcus; Torunn I Yock; Nancy Tarbell; Catherine A Billups; Jianrong Wu; Michael P Link
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

2.  Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.

Authors:  Gaetano Corazzelli
Journal:  Transl Pediatr       Date:  2013-07

3.  Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapy.

Authors:  Wolfgang Dörffel; Alexander Claviez; Heike Lüders; Ursula Rühl
Journal:  Transl Pediatr       Date:  2013-07

Review 4.  Cancer in adolescents and young adults in countries with limited resources.

Authors:  Ian Magrath; Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

5.  Hodgkin lymphoma at the paediatric oncology unit of gabriel touré teaching hospital, bamako, mali: 5-year experience.

Authors:  B Togo; F Traoré; A P Togo; C B Traoré; K Dumke; M Diawara; A A Diakité; M Sylla; F Traoré-Dicko; B Traoré; T Sidibé
Journal:  Adv Hematol       Date:  2011-02-10

6.  Pediatric lymphomas in Brazil.

Authors:  Gabriela Gualco; Claudete E Klumb; Glen N Barber; Lawrence M Weiss; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

7.  Breast Cancer Clinical Trials: The Landscape at the Uganda Cancer Institute and Lessons Learned.

Authors:  Manoj P Menon; Nixon Niyonzima; Julie Gralow; Jackson Orem
Journal:  JCO Glob Oncol       Date:  2021-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.